{"id":"https://openalex.org/W4386494902","doi":"https://doi.org/10.1371/journal.ppat.1011612","title":"Development of an antibody fused with an antimicrobial peptide targeting Pseudomonas aeruginosa: A new approach to prevent and treat bacterial infections","display_name":"Development of an antibody fused with an antimicrobial peptide targeting Pseudomonas aeruginosa: A new approach to prevent and treat bacterial infections","publication_year":2023,"publication_date":"2023-09-07","ids":{"openalex":"https://openalex.org/W4386494902","doi":"https://doi.org/10.1371/journal.ppat.1011612","pmid":"https://pubmed.ncbi.nlm.nih.gov/37676873","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10508631"},"language":"en","primary_location":{"id":"doi:10.1371/journal.ppat.1011612","doi":"https://doi.org/10.1371/journal.ppat.1011612","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.ppat.1011612","pdf_url":"https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1011612&type=printable","source":{"id":"https://openalex.org/S2004986","display_name":"PLoS Pathogens","issn_l":"1553-7366","issn":["1553-7366","1553-7374"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS Pathogens","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1011612&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108786734","display_name":"Kenneth D. Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110476","display_name":"Visterra (United States)","ror":"https://ror.org/01ph20k51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Johnson","raw_affiliation_strings":["Visterra, Inc., Waltham, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Visterra, Inc., Waltham, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210110476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080547278","display_name":"James C. Delaney","orcid":"https://orcid.org/0000-0002-8353-6497","observed_orcids":["https://orcid.org/0000-0002-8353-6497"]},"institutions":[{"id":"https://openalex.org/I4210110476","display_name":"Visterra (United States)","ror":"https://ror.org/01ph20k51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James C. Delaney","raw_affiliation_strings":["Visterra, Inc., Waltham, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Visterra, Inc., Waltham, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210110476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026371419","display_name":"Thomas Guillard","orcid":"https://orcid.org/0000-0002-3795-0398","observed_orcids":["https://orcid.org/0000-0002-3795-0398"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4387154171","display_name":"Pathologies Pulmonaires et Plasticit\u00e9 Cellulaire","ror":"https://ror.org/02w7ezv91","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4387154171","https://openalex.org/I96226040"]},{"id":"https://openalex.org/I96226040","display_name":"Universit\u00e9 de Reims Champagne-Ardenne","ror":"https://ror.org/03hypw319","country_code":"FR","type":"education","lineage":["https://openalex.org/I96226040"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Thomas Guillard","raw_affiliation_strings":["Inserm UMR-S 1250 P3 Cell, Universit\u00e9 de Reims-Champagne-Ardenne, Reims, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm UMR-S 1250 P3 Cell, Universit\u00e9 de Reims-Champagne-Ardenne, Reims, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4387154171","https://openalex.org/I96226040"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043318149","display_name":"Fany Reffuveille","orcid":"https://orcid.org/0000-0002-0753-3761","observed_orcids":["https://orcid.org/0000-0002-0753-3761"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4387154171","display_name":"Pathologies Pulmonaires et Plasticit\u00e9 Cellulaire","ror":"https://ror.org/02w7ezv91","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4387154171","https://openalex.org/I96226040"]},{"id":"https://openalex.org/I96226040","display_name":"Universit\u00e9 de Reims Champagne-Ardenne","ror":"https://ror.org/03hypw319","country_code":"FR","type":"education","lineage":["https://openalex.org/I96226040"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fany Reffuveille","raw_affiliation_strings":["Inserm UMR-S 1250 P3 Cell, Universit\u00e9 de Reims-Champagne-Ardenne, Reims, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm UMR-S 1250 P3 Cell, Universit\u00e9 de Reims-Champagne-Ardenne, Reims, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4387154171","https://openalex.org/I96226040"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jennifer Varin-Simon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4387154171","display_name":"Pathologies Pulmonaires et Plasticit\u00e9 Cellulaire","ror":"https://ror.org/02w7ezv91","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4387154171","https://openalex.org/I96226040"]},{"id":"https://openalex.org/I96226040","display_name":"Universit\u00e9 de Reims Champagne-Ardenne","ror":"https://ror.org/03hypw319","country_code":"FR","type":"education","lineage":["https://openalex.org/I96226040"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jennifer Varin-Simon","raw_affiliation_strings":["Inserm UMR-S 1250 P3 Cell, Universit\u00e9 de Reims-Champagne-Ardenne, Reims, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm UMR-S 1250 P3 Cell, Universit\u00e9 de Reims-Champagne-Ardenne, Reims, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4387154171","https://openalex.org/I96226040"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100399863","display_name":"Kai Li","orcid":"https://orcid.org/0000-0002-1746-7913","observed_orcids":["https://orcid.org/0000-0002-1746-7913"]},"institutions":[{"id":"https://openalex.org/I4210110476","display_name":"Visterra (United States)","ror":"https://ror.org/01ph20k51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kai Li","raw_affiliation_strings":["Visterra, Inc., Waltham, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Visterra, Inc., Waltham, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210110476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011518479","display_name":"Andrew M. Wollacott","orcid":"https://orcid.org/0000-0001-9848-8742","observed_orcids":["https://orcid.org/0000-0001-9848-8742"]},"institutions":[{"id":"https://openalex.org/I4210110476","display_name":"Visterra (United States)","ror":"https://ror.org/01ph20k51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Wollacott","raw_affiliation_strings":["Visterra, Inc., Waltham, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Visterra, Inc., Waltham, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210110476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058909491","display_name":"Eric Frapy","orcid":"https://orcid.org/0000-0002-2958-6960","observed_orcids":["https://orcid.org/0000-0002-2958-6960"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210086369","display_name":"Institut Necker Enfants Malades","ror":"https://ror.org/000nhq538","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210086369","https://openalex.org/I4210096427"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Eric Frapy","raw_affiliation_strings":["CNRS, INSERM, Institut Necker Enfants Malades-INEM, F-75015 Paris, France; Facult\u00e9 de M\u00e9decine, University of Paris City, Paris, France","Institut Necker Enfants-Malades, INSERM U1151, Universit\u00e9 Paris Cit\u00e9 Descartes, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNRS, INSERM, Institut Necker Enfants Malades-INEM, F-75015 Paris, France; Facult\u00e9 de M\u00e9decine, University of Paris City, Paris, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210086369"]},{"raw_affiliation_string":"Institut Necker Enfants-Malades, INSERM U1151, Universit\u00e9 Paris Cit\u00e9 Descartes, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210086369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021339328","display_name":"Surin K. Mong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Surin Mong","raw_affiliation_strings":["Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America","Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of Amrica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I63966007"]},{"raw_affiliation_string":"Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of Amrica","institution_ids":["https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052353564","display_name":"Hamid Tissire","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110476","display_name":"Visterra (United States)","ror":"https://ror.org/01ph20k51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hamid Tissire","raw_affiliation_strings":["Visterra, Inc., Waltham, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Visterra, Inc., Waltham, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210110476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101902961","display_name":"Karthik Viswanathan","orcid":"https://orcid.org/0000-0002-1288-9965","observed_orcids":["https://orcid.org/0000-0002-1288-9965"]},"institutions":[{"id":"https://openalex.org/I4210110476","display_name":"Visterra (United States)","ror":"https://ror.org/01ph20k51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karthik Viswanathan","raw_affiliation_strings":["Visterra, Inc., Waltham, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Visterra, Inc., Waltham, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210110476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055679097","display_name":"Fay\u00e7al Touti","orcid":"https://orcid.org/0000-0001-9021-0308","observed_orcids":["https://orcid.org/0000-0001-9021-0308"]},"institutions":[{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Faycal Touti","raw_affiliation_strings":["Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America","Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of Amrica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I63966007"]},{"raw_affiliation_string":"Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of Amrica","institution_ids":["https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042974567","display_name":"Gregory J. Babcock","orcid":"https://orcid.org/0000-0003-2155-2421","observed_orcids":["https://orcid.org/0000-0003-2155-2421"]},"institutions":[{"id":"https://openalex.org/I4210110476","display_name":"Visterra (United States)","ror":"https://ror.org/01ph20k51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory J. Babcock","raw_affiliation_strings":["Visterra, Inc., Waltham, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Visterra, Inc., Waltham, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210110476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034097399","display_name":"Zachary H. Shriver","orcid":"https://orcid.org/0000-0002-6582-8330","observed_orcids":["https://orcid.org/0000-0002-6582-8330"]},"institutions":[{"id":"https://openalex.org/I4210110476","display_name":"Visterra (United States)","ror":"https://ror.org/01ph20k51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110476"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Zachary Shriver","raw_affiliation_strings":["Visterra, Inc., Waltham, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Visterra, Inc., Waltham, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210110476"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021760386","display_name":"Bradley L. Pentelute","orcid":"https://orcid.org/0000-0002-7242-801X","observed_orcids":["https://orcid.org/0000-0002-7242-801X"]},"institutions":[{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradley L. Pentelute","raw_affiliation_strings":["Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America","Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of Amrica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America","institution_ids":["https://openalex.org/I63966007"]},{"raw_affiliation_string":"Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of Amrica","institution_ids":["https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018166623","display_name":"Obadiah J. Plante","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110476","display_name":"Visterra (United States)","ror":"https://ror.org/01ph20k51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210110476"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Obadiah Plante","raw_affiliation_strings":["Visterra, Inc., Waltham, Massachusetts, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Visterra, Inc., Waltham, Massachusetts, United States of America","institution_ids":["https://openalex.org/I4210110476"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063218720","display_name":"David Skurnik","orcid":"https://orcid.org/0000-0002-4205-9639","observed_orcids":["https://orcid.org/0000-0002-4205-9639"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I1288880153","display_name":"H\u00f4pital Necker-Enfants Malades","ror":"https://ror.org/05tr67282","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I1288880153","https://openalex.org/I4210097159","https://openalex.org/I4210120235"]},{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210086369","display_name":"Institut Necker Enfants Malades","ror":"https://ror.org/000nhq538","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210086369","https://openalex.org/I4210096427"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]}],"countries":["FR","US"],"is_corresponding":true,"raw_author_name":"David Skurnik","raw_affiliation_strings":["CNRS, INSERM, Institut Necker Enfants Malades-INEM, F-75015 Paris, France; Facult\u00e9 de M\u00e9decine, University of Paris City, Paris, France","Department of Clinical Microbiology, F\u00e9d\u00e9ration Hospitalo-Universitaire Pr\u00e9maturit\u00e9 (FHU PREMA), Necker-Enfants Malades University Hospital, Assistance Publique-H\u00f4pitaux de Paris, University of Paris City, Paris, France","Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America","Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of Amrica","Institut Necker Enfants-Malades, INSERM U1151, Universit\u00e9 Paris Cit\u00e9 Descartes, Paris, France","Service de Microbiologie, H\u00f4pital Necker-Enfants Malades, Assistance Publique-H\u00f4pitaux de Paris, Universit\u00e9 de Paris Cit\u00e9, Paris, France"],"raw_orcid":"https://orcid.org/0000-0002-4205-9639","affiliations":[{"raw_affiliation_string":"CNRS, INSERM, Institut Necker Enfants Malades-INEM, F-75015 Paris, France; Facult\u00e9 de M\u00e9decine, University of Paris City, Paris, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210086369"]},{"raw_affiliation_string":"Department of Clinical Microbiology, F\u00e9d\u00e9ration Hospitalo-Universitaire Pr\u00e9maturit\u00e9 (FHU PREMA), Necker-Enfants Malades University Hospital, Assistance Publique-H\u00f4pitaux de Paris, University of Paris City, Paris, France","institution_ids":["https://openalex.org/I1288880153","https://openalex.org/I204730241","https://openalex.org/I4210097159"]},{"raw_affiliation_string":"Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of Amrica","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Institut Necker Enfants-Malades, INSERM U1151, Universit\u00e9 Paris Cit\u00e9 Descartes, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210086369"]},{"raw_affiliation_string":"Service de Microbiologie, H\u00f4pital Necker-Enfants Malades, Assistance Publique-H\u00f4pitaux de Paris, Universit\u00e9 de Paris Cit\u00e9, Paris, France","institution_ids":["https://openalex.org/I1288880153","https://openalex.org/I204730241","https://openalex.org/I4210097159"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5034097399","https://openalex.org/A5063218720"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I1288880153","https://openalex.org/I1294671590","https://openalex.org/I136199984","https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210086369","https://openalex.org/I4210097159","https://openalex.org/I4210110476"],"apc_list":{"value":2655,"currency":"USD","value_usd":2655},"apc_paid":{"value":2841,"currency":"EUR","value_usd":3064},"fwci":4.9166,"has_fulltext":true,"cited_by_count":27,"citation_normalized_percentile":{"value":0.96568856,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"19","issue":"9","first_page":"e1011612","last_page":"e1011612"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.8525000214576721,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.8525000214576721,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.11159999668598175,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12526","display_name":"Antimicrobial agents and applications","score":0.019099999219179153,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9810000061988831},{"id":"https://openalex.org/keywords/antimicrobial-peptides","display_name":"antimicrobial peptides","score":0.9399999976158142},{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa","display_name":"Pseudomonas aeruginosa","score":0.9980000257492065},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.8460000157356262},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8820000290870667},{"id":"https://openalex.org/keywords/gram-negative-infections","display_name":"gram-negative bacterial infection","score":0.7120000123977661},{"id":"https://openalex.org/keywords/antibiotic-resistance","display_name":"antibiotic resistance","score":0.9319999814033508},{"id":"https://openalex.org/keywords/pulmonary-infection","display_name":"pulmonary infection","score":0.5730000138282776},{"id":"https://openalex.org/keywords/antibiotic-synergy","display_name":"antibiotic synergy","score":0.7699999809265137},{"id":"https://openalex.org/keywords/bactericidal-activity","display_name":"bactericidal activity","score":0.593999981880188}],"concepts":[{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.8798996210098267},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.7214324474334717},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.7205766439437866},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.714194118976593},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5891405344009399},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.5576283931732178},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5552689433097839},{"id":"https://openalex.org/C2778883795","wikidata":"https://www.wikidata.org/wiki/Q804517","display_name":"Pathogenic bacteria","level":3,"score":0.5126084685325623},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.45712512731552124},{"id":"https://openalex.org/C2776051709","wikidata":"https://www.wikidata.org/wiki/Q632006","display_name":"Gram-negative bacteria","level":4,"score":0.44252240657806396},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4290889501571655},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.41930192708969116},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24679455161094666},{"id":"https://openalex.org/C547475151","wikidata":"https://www.wikidata.org/wiki/Q25419","display_name":"Escherichia coli","level":3,"score":0.17547443509101868},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06018549203872681},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.05787914991378784},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000089882","descriptor_name":"Antimicrobial Peptides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008322","descriptor_name":"Mammals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011550","descriptor_name":"Pseudomonas aeruginosa","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1371/journal.ppat.1011612","doi":"https://doi.org/10.1371/journal.ppat.1011612","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.ppat.1011612","pdf_url":"https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1011612&type=printable","source":{"id":"https://openalex.org/S2004986","display_name":"PLoS Pathogens","issn_l":"1553-7366","issn":["1553-7366","1553-7374"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS Pathogens","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10508631","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10508631","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10508631/pdf/ppat.1011612.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS Pathog","raw_type":"Text"},{"id":"pmid:37676873","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37676873","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS pathogens","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-04205664v1","doi":null,"is_oa":false,"landing_page_url":"https://univ-reims.hal.science/hal-04205664","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS Pathogens, 2023, 19 (9), pp.e1011612. ⟨10.1371/journal.ppat.1011612⟩","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:8b565cd43cf347e9bb67ff626b5234bf","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/8b565cd43cf347e9bb67ff626b5234bf","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS Pathogens, Vol 19, Iss 9, p e1011612 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1371/journal.ppat.1011612","doi":"https://doi.org/10.1371/journal.ppat.1011612","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.ppat.1011612","pdf_url":"https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1011612&type=printable","source":{"id":"https://openalex.org/S2004986","display_name":"PLoS Pathogens","issn_l":"1553-7366","issn":["1553-7366","1553-7374"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS Pathogens","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3355713573","display_name":null,"funder_award_id":"1 IDSEP160030-01-02","funder_id":"https://openalex.org/F4320319116","funder_display_name":"Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator"},{"id":"https://openalex.org/G7675275562","display_name":null,"funder_award_id":"IDSEP160030","funder_id":"https://openalex.org/F4320319116","funder_display_name":"Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator"}],"funders":[{"id":"https://openalex.org/F4320319116","display_name":"Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator","ror":"https://ror.org/0381dsh28"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4386494902.pdf","grobid_xml":"https://content.openalex.org/works/W4386494902.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W1533816626","https://openalex.org/W1915856409","https://openalex.org/W1979192175","https://openalex.org/W1980982717","https://openalex.org/W1982240222","https://openalex.org/W1996344251","https://openalex.org/W2027109482","https://openalex.org/W2031448311","https://openalex.org/W2038681553","https://openalex.org/W2063558597","https://openalex.org/W2069107501","https://openalex.org/W2078365477","https://openalex.org/W2087071891","https://openalex.org/W2092196558","https://openalex.org/W2097506413","https://openalex.org/W2108975442","https://openalex.org/W2111734075","https://openalex.org/W2113324151","https://openalex.org/W2123844970","https://openalex.org/W2133316456","https://openalex.org/W2134100442","https://openalex.org/W2134308642","https://openalex.org/W2134985690","https://openalex.org/W2138911671","https://openalex.org/W2154556219","https://openalex.org/W2179304096","https://openalex.org/W2280404143","https://openalex.org/W2324215686","https://openalex.org/W2471612261","https://openalex.org/W2566553664","https://openalex.org/W2581307274","https://openalex.org/W2781850734","https://openalex.org/W2888065730","https://openalex.org/W2947604482","https://openalex.org/W2970103499","https://openalex.org/W2981853562","https://openalex.org/W2991330881","https://openalex.org/W3094549994","https://openalex.org/W3111531342","https://openalex.org/W4210968711","https://openalex.org/W4220992333","https://openalex.org/W4234317413","https://openalex.org/W4242318543","https://openalex.org/W4282928741","https://openalex.org/W4319164392"],"related_works":["https://openalex.org/W4315436592","https://openalex.org/W4405369889","https://openalex.org/W4416451576","https://openalex.org/W4365515828","https://openalex.org/W4381855039","https://openalex.org/W3149174883","https://openalex.org/W2981382667","https://openalex.org/W4200382207","https://openalex.org/W4386443216","https://openalex.org/W3164807433"],"abstract_inverted_index":{"The":[0],"increase":[1],"in":[2,186,191],"emerging":[3],"drug":[4],"resistant":[5],"Gram-negative":[6,47,100],"bacterial":[7],"infections":[8,48],"is":[9,16,37],"a":[10,76,81,97,131,192],"global":[11],"concern.":[12],"In":[13,55],"addition,":[14],"there":[15,36],"growing":[17],"recognition":[18],"that":[19,49,69,135,173],"compromising":[20],"the":[21,24,38,73,86,122,126,137,174],"microbiota":[22],"through":[23,80],"use":[25],"of":[26,75,90,125,130,139,149,181],"broad-spectrum":[27],"antibiotics":[28],"can":[29],"impact":[30],"long":[31],"term":[32],"patient":[33],"outcomes.":[34],"Therefore,":[35],"need":[39],"to":[40,45,121],"develop":[41],"new":[42],"bactericidal":[43],"strategies":[44],"combat":[46],"would":[50],"address":[51],"these":[52],"specific":[53,77,198],"issues.":[54],"this":[56,110,187],"study,":[57],"we":[58,112,171],"report":[59],"and":[60,159],"characterize":[61],"one":[62],"such":[63],"approach,":[64],"an":[65,91,114,118],"antibody-drug":[66],"conjugate":[67],"(ADC)":[68],"combines":[70],"(i)":[71],"targeting":[72,197],"surface":[74],"pathogenic":[78,99,199],"organism":[79],"monoclonal":[82,132],"antibody":[83],"with":[84,103,178],"(ii)":[85],"high":[87],"killing":[88],"activity":[89],"antimicrobial":[92,119],"peptide.":[93],"We":[94],"focused":[95],"on":[96],"major":[98],"bacterium":[101],"associated":[102],"antibacterial":[104],"resistance:":[105],"Pseudomonas":[106],"aeruginosa.":[107],"To":[108],"target":[109],"organism,":[111],"designed":[113],"ADC":[115,144,175],"by":[116],"fusing":[117],"peptide":[120],"C-terminal":[123],"end":[124],"VH":[127],"and/or":[128],"VL-chain":[129],"antibody,":[133],"VSX,":[134],"targets":[136],"core":[138],"P.":[140,156,163],"aeruginosa":[141,157,164],"lipopolysaccharide.":[142],"This":[143,183],"demonstrates":[145],"appropriately":[146],"minimal":[147],"levels":[148],"toxicity":[150],"against":[151],"mammalian":[152],"cells,":[153],"rapidly":[154],"kills":[155],"strains,":[158],"protects":[160],"mice":[161],"from":[162],"lung":[165],"infection":[166],"when":[167],"administered":[168],"therapeutically.":[169],"Furthermore,":[170],"found":[172],"was":[176],"synergistic":[177],"several":[179],"classes":[180],"antibiotics.":[182],"approach":[184],"described":[185],"study":[188],"might":[189],"result":[190],"broadly":[193],"useful":[194],"strategy":[195],"for":[196],"microorganisms":[200],"without":[201],"further":[202],"augmenting":[203],"antibiotic":[204],"resistance.":[205]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-09-07T00:00:00"}